Mahmoud Abunasser

King Hussein Cancer Center — JO

Medicine · Health Sciences

9h-index216citations28works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(7), Advanced Breast Cancer Therapies(7), Breast Cancer Treatment Studies(6), BRCA gene mutations in cancer(5), Cancer Treatment and Pharmacology(5)

Publications28 total

Prevalence and predictors of Do-Not-Resuscitate orders among advanced cancer patients receiving palliative care at a tertiary cancer center in Jordan: a 10-year retrospective analysis
2025Open Access
Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
Frontiers in Oncology·2025· 4 citedOpen Access
Abstract P3-10-01: Interval Improvement in Overall Survival of Patients with De Novo Metastatic Breast Cancer. Real World Data from a Resource-Restricted Country
Clinical Cancer Research·2025
Abstract P3-12-02: Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant in Hormone Receptor (HR)-Positive, HER2-Negative Premenopausal Women with Metastatic Breast Cancer. Real World Data from a Resource-Restricted Country
Clinical Cancer Research·2025
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country
ImmunoTargets and Therapy·2024· 3 citedOpen Access
Abstract PO4-03-03: Conditional Use of Serial Serum Tumor Markers CA 15.3 and CEA as Predictors of Disease Relapse in Patients with High-Risk Early-Stage Breast Cancer
Cancer Research·2024
Abstract PO2-04-12: From Clinical Trials to Clinical Practice; Real World Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2- Negative Metastatic Breast Cancer
Cancer Research·2024
344P Epidemiological analysis and overall survival of female breast cancer in a developing middle eastern country over 18 years
Annals of Oncology·2023Open Access
Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan
Journal of Multidisciplinary Healthcare·2023· 2 citedOpen Access
Decision-Making Preferences among Advanced Cancer Patients in a Palliative Setting in Jordan
International Journal of Environmental Research and Public Health·2023· 6 citedOpen Access
Validation of the Arabic Version of the Edmonton Symptom Assessment System
International Journal of Environmental Research and Public Health·2023· 3 citedOpen Access
Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
Frontiers in Oncology·2022· 14 citedOpen Access
Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review
Annals of Medicine and Surgery·2022· 3 citedOpen Access
Abstract P4-02-15: Thromboembolic events (TEE) in patients with HER2-negative, hormone receptor-positive metastatic breast cancer treated with Ribociclib combined with Letrozole or Fulvestrant. Real-world data
Cancer Research·2022
Development and assessment of a natural language processing model to identify residential instability in electronic health records’ unstructured data: a comparison of 3 integrated healthcare delivery systems
JAMIA Open·2022· 28 citedOpen Access
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
SHILAP Revista de lepidopterología·2022· 17 citedOpen Access
A Pilot Study to Improve the Use of Electronic Health Records for Identification of Patients with Social Determinants of Health Challenges: A Collaboration of Johns Hopkins Health System and Kaiser Permanente
Health Services Research·2021· 1 citedOpen Access
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
Scientific Reports·2021· 13 citedOpen Access
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
Cancer Management and Research·2021· 11 citedOpen Access
Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer
Cureus·2021· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Hikmat Abdel‐Razeq(23), Hazem Abdulelah(8), Baha’ Sharaf(8), Sarah Edaily(8), Faris Tamimi(7), Ayat Taqash(5), Osama Salama(5), Rayan Bater(5), Omar Shamieh(5), Anas Zayed(5), Asem Mansour(4), Salwa Saadeh(4), Lama Abujamous(4), Suhaib Khater(4), Sarah Abdel-Razeq(4), Mohammad Ibrahim(3), Rashid Abdel-Razeq(3), Sara Edaily(3), Mohammad Al-Omari(3), Amal Al-Tabba(3)